email

US AND CHINA PERIPHERAL ARTERY INTERVENTIONS (PAD) MARKET REPORT A Syndicated report based on survey with 100 Performing Doctors in each country The first-ever report that coverspatient pathways, treatment selection criteria, and standard of care for PAD interventions. The report covers several trends such as:
1 Impact of FDA update on drug coated device on performer’s havior   2 Selection criteria used by doctors to select type of therapy and products   3 Role of TCAR in Carotid artery revascularization procedures   4 Atherectomy technique that will have maximum adoption in future   5 PAD High growth interventions and products with highest growth potential   6 Procedure break-up by disease stage and artery-type A COMPREHENSIVE REPORT WITH QUALITATIVE AND QUANTITATIVE INSIGHTS DEVELOPED BY CETAS' VASCULAR INTERVENTIONS TEAM Reports available for: USA and China   Click here to view the Table of Contents   Upcoming Markets: Germany, UK, and Japan   Click here for a demo and price quote

FIRST-EVER SYNDICATED REPORT BASED ON STATISTICALLY ROBUST PRIMARY RESEARCH WITH DOCTORS FINDINGS ARE BASED ON: Qualitative and Quantitative with performing doctors Statistically robust sample size; 90% Confidence Level Key Opinion Leader Validation   FIRST-EVER SYNDICATED REPORT THAT INCLUDES STANDARD OF CARE (SOC)THAT IS DEFINED OVER 5 PS Physician Patient Payor Provider     Policy FIRST-EVER SYNDICATED REPORT THAT CAPTURES PHYSICIANPREFERENCES & PERCEPTIONS: Performer's challenges and unmet needs Future trends and game-changers Best-in-class brands across 10 critical KPIs   THE KEY METRICS THAT THE REPORT CAPTURES ARE ‘PATIENTS TREATED’OR ‘LIVES-SAVED’Procedure break-up by Indications Technology/ Modality test Physician preferences Others ABOUT CETAS HEALTHCARE

AND MANY MORE